Loading...
Ascend Wellness Holdings, Inc.
AAWH•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.43
$0.02(4.78%)
Ascend Wellness Holdings, Inc. (AAWH) Financial Performance & Income Statement Overview
Review Ascend Wellness Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.29%
↑ 8.29%
Operating Income Growth
230.81%
↑ 230.81%
Net Income Growth
-76.28%
↓ 76.28%
Operating Cash Flow Growth
-2.71%
↓ 2.71%
Operating Margin
0.85%
↑ 0.85%
Gross Margin
31.38%
↑ 31.38%
Net Profit Margin
-15.73%
↓ 15.73%
ROE
-104.90%
↓ 104.90%
ROIC
0.60%
↑ 0.60%
Ascend Wellness Holdings, Inc. (AAWH) Income Statement & Financial Overview
Review Ascend Wellness Holdings, Inc.'s (AAWH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $136.006M | $141.65M | $141.54M | $142.41M |
| Cost of Revenue | $89.14M | $97.92M | $99.96M | $99.09M |
| Gross Profit | $46.87M | $43.73M | $41.57M | $43.32M |
| Gross Profit Ratio | $0.34 | $0.31 | $0.29 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $31.82M | $46.15M | $34.52M | $40.60M |
| Operating Expenses | $40.77M | $46.15M | $43.09M | $40.60M |
| Total Costs & Expenses | $129.91M | $144.06M | $143.06M | $139.69M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $11.71M | $11.006M | $8.54M | $8.54M |
| Depreciation & Amortization | $17.98M | $17.11M | $16.33M | $16.49M |
| EBITDA | $23.69M | $9.63M | $15.19M | $19.37M |
| EBITDA Ratio | $0.17 | $0.07 | $0.11 | $0.14 |
| Operating Income | $6.10M | -$2.42M | -$1.52M | $2.71M |
| Operating Income Ratio | $0.04 | -$0.02 | -$0.01 | $0.02 |
| Other Income/Expenses (Net) | -$12.10M | -$16.07M | -$8.16M | -$8.23M |
| Income Before Tax | -$6.002M | -$18.49M | -$9.68M | -$5.65M |
| Income Before Tax Ratio | -$0.04 | -$0.13 | -$0.07 | -$0.04 |
| Income Tax Expense | $10.79M | $9.77M | $12.11M | $12.51M |
| Net Income | -$16.79M | -$28.26M | -$21.78M | -$18.16M |
| Net Income Ratio | -$0.12 | -$0.20 | -$0.15 | -$0.13 |
| EPS | -$0.08 | -$0.13 | -$0.10 | -$0.09 |
| Diluted EPS | -$0.08 | -$0.13 | -$0.10 | -$0.09 |
| Weighted Avg Shares Outstanding | $213.33M | $214.29M | $213.16M | $208.95M |
| Weighted Avg Shares Outstanding (Diluted) | $213.33M | $214.29M | $213.16M | $208.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan